ON
🔍
← Back to feed
XKMedicine2 days ago

Suspicion of a medical product, stocks are frozen at Mitrovica Hospital

A total of 1,432 units of the medical product 'Compound Sodium Lectate Intravenous Infusion' have been blocked at the Sami Haxhibeqiri Regional Hospital in Mitrovica. The hospital's Clinical and University Health Service stated that the issue was raised by the responsible pharmacist, who suspected the solution might not meet the specified standards for the product. The hospital has indicated that results will be published after laboratory analyses and professional evaluations are completed. According to the notification from the State Agency for Medicines and Medical Devices (SHSKUK), the Phyt

19 qershor 2026 12:51

Shpërndaje në:

1432 solucione mjekësore “Compound Sodium Lectate Intravenous Infusion” prej 500 mililitrash janë bllokuar nga barnatorja e Spitalit Rajonal “Sami Haxhibeqiri” në Mitrovicë. Shërbimi Spitalor Klinik dhe Universitar njoftoi se rasti u ngrit nga farmacistja përgjegjëse e barnatores, e cila dyshonte se solucioni mund të mos ishte brenda specifikave të përcaktuara për produktin.

SHSKUK ka deklaruar se gjetjet do të publikohet pas përfundimit të analizave laboratorike dhe vlerësimeve profesionale.

“Më 17.06.2026, Inspektorati Farmaceutik ka kryer inspektim në barnatoren e spitalit, ku është verifikuar gjendja e raportuar për produktin në fjalë. Përmes procesverbalit, Inspektorati Farmaceutik ka urdhëruar bllokimin e 1,432 njësive të produktit medicinal Compound Sodium Lactate Intravenous Infusion BP 500 ml deri në përfundimin e analizave laboratorike dhe procedurave përkatëse vlerësuese”, thuhet në njoftimin e SHSKUK-së.

Read the full article at Koha.net →
Source document: State Agency for Medicines and Medical Devices (SHSKUK)

1 reports

Koha.netIndependentCenter2 days ago
Suspicion of a medical product, stocks are frozen at Mitrovica Hospital

A total of 1,432 units of the medical product 'Compound Sodium Lectate Intravenous Infusion' have been blocked at the Sami Haxhibeqiri Regional Hospital in Mitrovica. The hospital's Clinical and University Health Service stated that the issue was raised by the responsible pharmacist, who suspected the solution might not meet the specified standards for the product. The hospital has indicated that results will be published after laboratory analyses and professional evaluations are completed. According to the notification from the State Agency for Medicines and Medical Devices (SHSKUK), the Phyt

Bias read (Center): The article reports on a medical product being blocked due to potential quality concerns. It provides factual information without apparent ideological framing, focusing on procedural actions taken by the hospital and regulatory authorities.

Official sources cited

  • government State Agency for Medicines and Medical Devices (SHSKUK)

Go to the primary sources (1)

The official sources this coverage is built on. Read them directly to bypass framing.

  • governmentState Agency for Medicines and Medical Devices (SHSKUK)